Bio-Techne (TECH) Net Income towards Common Stockholders (2009 - 2026)

Bio-Techne has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $51.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 125.99% year-over-year to $51.0 million; the trailing twelve-month figure through Mar 2026 stood at $22.7 million (down 71.78% YoY), and the FY2025 full-year result was -$13.4 million, down 111.46% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $51.0 million, up from $38.0 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $89.7 million in Q3 2022, with the low at -$104.5 million in Q2 2025.
• Average Net Income towards Common Stockholders over 5 years is $35.8 million, with a median of $45.7 million recorded in 2023.
• Year-over-year, Net Income towards Common Stockholders surged 193.98% in 2022 and tumbled 899.35% in 2025.
• Tracing TECH's Net Income towards Common Stockholders over 5 years: stood at $50.0 million in 2022, then plunged by 45.08% to $27.5 million in 2023, then climbed by 27.03% to $34.9 million in 2024, then climbed by 8.94% to $38.0 million in 2025, then surged by 34.3% to $51.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $51.0 million (Q1 2026), $38.0 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.

Peer Comparison